LAMEA Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025

List of Tables

The Latin America, Middle East and Africa Computational Pathology Market would witness market growth of 8.9% CAGR during the forecast period (2025-2032).

The Brazil market dominated the LAMEA Computational Pathology Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $38.9 million by 2032. The Argentina market is showcasing a CAGR of 9.7% during (2025 - 2032). Additionally, The UAE market would register a CAGR of 7.8% during (2025 - 2032).

Computational tools can identify early signs of coronary artery disease or myocardial infarction by analyzing tissue samples from the heart or vascular tissues. These tools help assess the extent of damage and predict potential outcomes, thus aiding in personalized treatment planning. These pathology also supports microbiology by enabling the analysis of microbial pathogens present in human tissue samples.

By automating the detection of pathogens in digital images, this technology accelerates diagnosis and treatment, especially in complex or rare infections. The adoption of this pathology technologies has grown rapidly, largely driven by the need for more efficient, accurate, and scalable diagnostic tools. As healthcare systems seek to modernize and integrate more advanced technologies, this pathology has emerged as a key area for improvement.

Brazil's burgeoning AI sector, with over US$1 billion in spending in 2023-a 33% year-over-year growth-represents a critical catalyst for developing these pathology solutions. Intelligent Process Automation (IPA) investment, which reached US$214 million in the same year, underscores a national commitment to advanced data processing and automated diagnostics. This ecosystem provides fertile ground for computational pathology, which relies heavily on AI and machine learning algorithms to analyze medical images and data with higher accuracy and speed. In the UAE, the government's proactive approach to healthcare-evident in the allocation of 8.4% of the USD 15.8 billion federal budget for 2022-demonstrates its dedication to modernizing the sector. UAE Vision 2040 further emphasizes healthcare as a strategic priority, making the country a hub for regional healthcare innovation and distribution. This emphasis on digital transformation and quality care creates significant opportunities for adopting computational pathology. In conclusion, the synergistic rise in AI investment in Brazil, strategic healthcare prioritization in the UAE, and the urgent need to tackle chronic diseases in Saudi Arabia are collectively shaping a conducive environment for market growth.

Based on Component, the market is segmented into Software and Services. Based on Application, the market is segmented into Disease Diagnosis, Drug Discovery & Development, and Academic Research. Based on End-use, the market is segmented into Hospitals and Diagnostic Labs, Biotechnology & Pharmaceutical Companies, Academic and Research Institutes, and Other End-use. Based on Technology, the market is segmented into Machine Learning (ML), (Deep Learning and Other Machine Learning (ML)), Computer Vision, Natural Language Processing (NLP) Models, and Other Technology. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

Koninklijke Philips N.V.
F. Hoffmann-La Roche Ltd.
PathAI, Inc.
Hamamatsu Photonics K.K.
Olympus Corporation
Visiopharm A/S
Mikroscan Technologies, Inc.
MindPeak GmbH
Indica Labs, LLC
Nucleai, Inc. (Nucleai)

LAMEA Computational Pathology Market Report Segmentation

By Component

Software
Services

By Application

Disease Diagnosis
Drug Discovery & Development
Academic Research

By End-use

Hospitals and Diagnostic Labs
Biotechnology & Pharmaceutical Companies
Academic and Research Institutes
Other End-use

By Technology

Machine Learning (ML)
- Deep Learning
- Other Machine Learning (ML)
Computer Vision
Natural Language Processing (NLP) Models
Other Technology

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA Computational Pathology Market, by Component
- 1.4.2 LAMEA Computational Pathology Market, by Application
- 1.4.3 LAMEA Computational Pathology Market, by End-use
- 1.4.4 LAMEA Computational Pathology Market, by Technology
- 1.4.5 LAMEA Computational Pathology Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges

Chapter 4. Competition Analysis - Global

4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
4.3 Market Share Analysis, 2024
4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2021-2025)
- 4.4.2 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
4.5 Porter Five Forces Analysis

Chapter 5. LAMEA Computational Pathology Market by Component

5.1 LAMEA Software Market by Country
5.2 LAMEA Services Market by Country

Chapter 6. LAMEA Computational Pathology Market by Application

6.1 LAMEA Disease Diagnosis Market by Country
6.2 LAMEA Drug Discovery & Development Market by Country
6.3 LAMEA Academic Research Market by Country

Chapter 7. LAMEA Computational Pathology Market by End-use

7.1 LAMEA Hospitals and Diagnostic Labs Market by Country
7.2 LAMEA Biotechnology & Pharmaceutical Companies Market by Country
7.3 LAMEA Academic and Research Institutes Market by Country
7.4 LAMEA Other End-use Market by Country

Chapter 8. LAMEA Computational Pathology Market by Technology

8.1 LAMEA Machine Learning (ML) Market by Country
8.2 LAMEA Computational Pathology Market by Machine Learning (ML) Type
- 8.2.1 LAMEA Deep Learning Market by Country
- 8.2.2 LAMEA Other Machine Learning (ML) Market by Country
8.3 LAMEA Computer Vision Market by Country
8.4 LAMEA Natural Language Processing (NLP) Models Market by Country
8.5 LAMEA Other Technology Market by Country

Chapter 9. LAMEA Computational Pathology Market by Country

9.1 Brazil Computational Pathology Market
- 9.1.1 Brazil Computational Pathology Market by Component
- 9.1.2 Brazil Computational Pathology Market by Application
- 9.1.3 Brazil Computational Pathology Market by End-use
- 9.1.4 Brazil Computational Pathology Market by Technology
  - 9.1.4.1 Brazil Computational Pathology Market by Machine Learning (ML) Type
9.2 Argentina Computational Pathology Market
- 9.2.1 Argentina Computational Pathology Market by Component
- 9.2.2 Argentina Computational Pathology Market by Application
- 9.2.3 Argentina Computational Pathology Market by End-use
- 9.2.4 Argentina Computational Pathology Market by Technology
  - 9.2.4.1 Argentina Computational Pathology Market by Machine Learning (ML) Type
9.3 UAE Computational Pathology Market
- 9.3.1 UAE Computational Pathology Market by Component
- 9.3.2 UAE Computational Pathology Market by Application
- 9.3.3 UAE Computational Pathology Market by End-use
- 9.3.4 UAE Computational Pathology Market by Technology
  - 9.3.4.1 UAE Computational Pathology Market by Machine Learning (ML) Type
9.4 Saudi Arabia Computational Pathology Market
- 9.4.1 Saudi Arabia Computational Pathology Market by Component
- 9.4.2 Saudi Arabia Computational Pathology Market by Application
- 9.4.3 Saudi Arabia Computational Pathology Market by End-use
- 9.4.4 Saudi Arabia Computational Pathology Market by Technology
  - 9.4.4.1 Saudi Arabia Computational Pathology Market by Machine Learning (ML) Type
9.5 South Africa Computational Pathology Market
- 9.5.1 South Africa Computational Pathology Market by Component
- 9.5.2 South Africa Computational Pathology Market by Application
- 9.5.3 South Africa Computational Pathology Market by End-use
- 9.5.4 South Africa Computational Pathology Market by Technology
  - 9.5.4.1 South Africa Computational Pathology Market by Machine Learning (ML) Type
9.6 Nigeria Computational Pathology Market
- 9.6.1 Nigeria Computational Pathology Market by Component
- 9.6.2 Nigeria Computational Pathology Market by Application
- 9.6.3 Nigeria Computational Pathology Market by End-use
- 9.6.4 Nigeria Computational Pathology Market by Technology
  - 9.6.4.1 Nigeria Computational Pathology Market by Machine Learning (ML) Type
9.7 Rest of LAMEA Computational Pathology Market
- 9.7.1 Rest of LAMEA Computational Pathology Market by Component
- 9.7.2 Rest of LAMEA Computational Pathology Market by Application
- 9.7.3 Rest of LAMEA Computational Pathology Market by End-use
- 9.7.4 Rest of LAMEA Computational Pathology Market by Technology
  - 9.7.4.1 Rest of LAMEA Computational Pathology Market by Machine Learning (ML) Type

Chapter 10. Company Profiles

10.1 Koninklijke Philips N.V.
- 10.1.1 Company Overview
- 10.1.2 Financial Analysis
- 10.1.3 Segmental and Regional Analysis
- 10.1.4 Research & Development Expense
- 10.1.5 Recent strategies and developments:
  - 10.1.5.1 Partnerships, Collaborations, and Agreements:
- 10.1.6 SWOT Analysis
10.2 F. Hoffmann-La Roche Ltd.
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
  - 10.2.5.1 Partnerships, Collaborations, and Agreements:
  - 10.2.5.2 Product Launches and Product Expansions:
- 10.2.6 SWOT Analysis
10.3 PathAI, Inc.
- 10.3.1 Company Overview
- 10.3.2 Recent strategies and developments:
  - 10.3.2.1 Partnerships, Collaborations, and Agreements:
  - 10.3.2.2 Product Launches and Product Expansions:
- 10.3.3 SWOT Analysis
10.4 Hamamatsu Photonics K.K.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Segmental Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 SWOT Analysis
10.5 Olympus Corporation
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 SWOT Analysis
10.6 Visiopharm A/S
- 10.6.1 Company Overview
- 10.6.2 Recent strategies and developments:
  - 10.6.2.1 Partnerships, Collaborations, and Agreements:
  - 10.6.2.2 Product Launches and Product Expansions:
- 10.6.3 SWOT Analysis
10.7 Mikroscan Technologies, Inc.
- 10.7.1 Company Overview
10.8 MindPeak GmbH
- 10.8.1 Company Overview
- 10.8.2 Recent strategies and developments:
  - 10.8.2.1 Partnerships, Collaborations, and Agreements:
10.9 Indica Labs, Inc.
- 10.9.1 Company Overview
- 10.9.2 Recent strategies and developments:
  - 10.9.2.1 Partnerships, Collaborations, and Agreements:
- 10.9.3 SWOT Analysis
10.10. Nucleai, Inc. (Nucleai)
- 10.10.1 Company Overview
- 10.10.2 Recent strategies and developments:
  - 10.10.2.1 Partnerships, Collaborations, and Agreements:

LIST OF TABLES

TABLE 1 LAMEA Computational Pathology Market, 2021 - 2024, USD Million
TABLE 2 LAMEA Computational Pathology Market, 2025 - 2032, USD Million
TABLE 3 Partnerships, Collaborations and Agreements- Computational Pathology Market
TABLE 4 Product Launches And Product Expansions- Computational Pathology Market
TABLE 5 LAMEA Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 6 LAMEA Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 7 LAMEA Software Market by Country, 2021 - 2024, USD Million
TABLE 8 LAMEA Software Market by Country, 2025 - 2032, USD Million
TABLE 9 LAMEA Services Market by Country, 2021 - 2024, USD Million
TABLE 10 LAMEA Services Market by Country, 2025 - 2032, USD Million
TABLE 11 LAMEA Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 12 LAMEA Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 13 LAMEA Disease Diagnosis Market by Country, 2021 - 2024, USD Million
TABLE 14 LAMEA Disease Diagnosis Market by Country, 2025 - 2032, USD Million
TABLE 15 LAMEA Drug Discovery & Development Market by Country, 2021 - 2024, USD Million
TABLE 16 LAMEA Drug Discovery & Development Market by Country, 2025 - 2032, USD Million
TABLE 17 LAMEA Academic Research Market by Country, 2021 - 2024, USD Million
TABLE 18 LAMEA Academic Research Market by Country, 2025 - 2032, USD Million
TABLE 19 LAMEA Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 20 LAMEA Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 21 LAMEA Hospitals and Diagnostic Labs Market by Country, 2021 - 2024, USD Million
TABLE 22 LAMEA Hospitals and Diagnostic Labs Market by Country, 2025 - 2032, USD Million
TABLE 23 LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2021 - 2024, USD Million
TABLE 24 LAMEA Biotechnology & Pharmaceutical Companies Market by Country, 2025 - 2032, USD Million
TABLE 25 LAMEA Academic and Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 26 LAMEA Academic and Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 27 LAMEA Other End-use Market by Country, 2021 - 2024, USD Million
TABLE 28 LAMEA Other End-use Market by Country, 2025 - 2032, USD Million
TABLE 29 LAMEA Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 30 LAMEA Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 31 LAMEA Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
TABLE 32 LAMEA Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
TABLE 33 LAMEA Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 34 LAMEA Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 35 LAMEA Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 36 LAMEA Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 37 LAMEA Other Machine Learning (ML) Market by Country, 2021 - 2024, USD Million
TABLE 38 LAMEA Other Machine Learning (ML) Market by Country, 2025 - 2032, USD Million
TABLE 39 LAMEA Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 40 LAMEA Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 41 LAMEA Natural Language Processing (NLP) Models Market by Country, 2021 - 2024, USD Million
TABLE 42 LAMEA Natural Language Processing (NLP) Models Market by Country, 2025 - 2032, USD Million
TABLE 43 LAMEA Other Technology Market by Country, 2021 - 2024, USD Million
TABLE 44 LAMEA Other Technology Market by Country, 2025 - 2032, USD Million
TABLE 45 LAMEA Computational Pathology Market by Country, 2021 - 2024, USD Million
TABLE 46 LAMEA Computational Pathology Market by Country, 2025 - 2032, USD Million
TABLE 47 Brazil Computational Pathology Market, 2021 - 2024, USD Million
TABLE 48 Brazil Computational Pathology Market, 2025 - 2032, USD Million
TABLE 49 Brazil Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 50 Brazil Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 51 Brazil Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 52 Brazil Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 53 Brazil Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 54 Brazil Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 55 Brazil Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 56 Brazil Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 57 Brazil Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 58 Brazil Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 59 Argentina Computational Pathology Market, 2021 - 2024, USD Million
TABLE 60 Argentina Computational Pathology Market, 2025 - 2032, USD Million
TABLE 61 Argentina Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 62 Argentina Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 63 Argentina Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 64 Argentina Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 65 Argentina Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 66 Argentina Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 67 Argentina Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 68 Argentina Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 69 Argentina Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 70 Argentina Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 71 UAE Computational Pathology Market, 2021 - 2024, USD Million
TABLE 72 UAE Computational Pathology Market, 2025 - 2032, USD Million
TABLE 73 UAE Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 74 UAE Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 75 UAE Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 76 UAE Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 77 UAE Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 78 UAE Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 79 UAE Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 80 UAE Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 81 UAE Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 82 UAE Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 83 Saudi Arabia Computational Pathology Market, 2021 - 2024, USD Million
TABLE 84 Saudi Arabia Computational Pathology Market, 2025 - 2032, USD Million
TABLE 85 Saudi Arabia Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 86 Saudi Arabia Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 87 Saudi Arabia Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 88 Saudi Arabia Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 89 Saudi Arabia Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 90 Saudi Arabia Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 91 Saudi Arabia Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 92 Saudi Arabia Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 93 Saudi Arabia Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 94 Saudi Arabia Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 95 South Africa Computational Pathology Market, 2021 - 2024, USD Million
TABLE 96 South Africa Computational Pathology Market, 2025 - 2032, USD Million
TABLE 97 South Africa Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 98 South Africa Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 99 South Africa Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 100 South Africa Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 101 South Africa Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 102 South Africa Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 103 South Africa Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 104 South Africa Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 105 South Africa Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 106 South Africa Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 107 Nigeria Computational Pathology Market, 2021 - 2024, USD Million
TABLE 108 Nigeria Computational Pathology Market, 2025 - 2032, USD Million
TABLE 109 Nigeria Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 110 Nigeria Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 111 Nigeria Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 112 Nigeria Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 113 Nigeria Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 114 Nigeria Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 115 Nigeria Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 116 Nigeria Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 117 Nigeria Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 118 Nigeria Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 119 Rest of LAMEA Computational Pathology Market, 2021 - 2024, USD Million
TABLE 120 Rest of LAMEA Computational Pathology Market, 2025 - 2032, USD Million
TABLE 121 Rest of LAMEA Computational Pathology Market by Component, 2021 - 2024, USD Million
TABLE 122 Rest of LAMEA Computational Pathology Market by Component, 2025 - 2032, USD Million
TABLE 123 Rest of LAMEA Computational Pathology Market by Application, 2021 - 2024, USD Million
TABLE 124 Rest of LAMEA Computational Pathology Market by Application, 2025 - 2032, USD Million
TABLE 125 Rest of LAMEA Computational Pathology Market by End-use, 2021 - 2024, USD Million
TABLE 126 Rest of LAMEA Computational Pathology Market by End-use, 2025 - 2032, USD Million
TABLE 127 Rest of LAMEA Computational Pathology Market by Technology, 2021 - 2024, USD Million
TABLE 128 Rest of LAMEA Computational Pathology Market by Technology, 2025 - 2032, USD Million
TABLE 129 Rest of LAMEA Computational Pathology Market by Machine Learning (ML) Type, 2021 - 2024, USD Million
TABLE 130 Rest of LAMEA Computational Pathology Market by Machine Learning (ML) Type, 2025 - 2032, USD Million
TABLE 131 Key Information - Koninklijke Philips N.V.
TABLE 132 Key Information - F. Hoffmann-La Roche Ltd.
TABLE 133 Key Information - PathAI, Inc.
TABLE 134 key information - Hamamatsu Photonics K.K.
TABLE 135 Key Information - Olympus Corporation
TABLE 136 Key Information - Visiopharm A/S
TABLE 137 Key Information - Mikroscan Technologies, Inc.
TABLE 138 Key Information - MindPeak GmbH
TABLE 139 Key Information - Indica Labs, Inc.
TABLE 140 Key Information - Nucleai, Inc.

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 LAMEA Computational Pathology Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting Computational Pathology Market
FIG 4 KBV Cardinal Matrix
FIG 5 Market Share Analysis, 2024
FIG 6 Key Leading Strategies: Percentage Distribution (2021-2025)
FIG 7 Key Strategic Move: (Partnerships, Collaborations & Agreements : 2022, Mar - 2025, Feb) Leading Players
FIG 8 Porter's Five Forces Analysis - Computational Pathology Market
FIG 9 LAMEA Computational Pathology Market share by Component, 2024
FIG 10 LAMEA Computational Pathology Market share by Component, 2032
FIG 11 LAMEA Computational Pathology Market by Component, 2021 - 2032, USD Million
FIG 12 LAMEA Computational Pathology Market share by Application, 2024
FIG 13 LAMEA Computational Pathology Market share by Application, 2032
FIG 14 LAMEA Computational Pathology Market by Application, 2021 - 2032, USD Million
FIG 15 LAMEA Computational Pathology Market share by End-use, 2024
FIG 16 LAMEA Computational Pathology Market share by End-use, 2032
FIG 17 LAMEA Computational Pathology Market by End-use, 2021 - 2032, USD Million
FIG 18 LAMEA Computational Pathology Market share by Technology, 2024
FIG 19 LAMEA Computational Pathology Market share by Technology, 2032
FIG 20 LAMEA Computational Pathology Market by Technology, 2021 - 2032, USD Million
FIG 21 LAMEA Computational Pathology Market share by Country, 2024
FIG 22 LAMEA Computational Pathology Market share by Country, 2032
FIG 23 LAMEA Computational Pathology Market by Country, 2021 - 2032, USD Million
FIG 24 SWOT Analysis: Koninklijke Philips N.V.
FIG 25 Recent strategies and developments: F. Hoffmann-La Roche Ltd.
FIG 26 SWOT Analysis: F. Hoffmann-La Roche Ltd.
FIG 27 Recent strategies and developments: PathAI, Inc.
FIG 28 Swot Analysis: PathAI, Inc.
FIG 29 Swot analysis: Hamamatsu Photonics K.K.
FIG 30 SWOT Analysis: Olympus Corporation
FIG 31 Recent strategies and developments: Visiopharm A/S
FIG 32 Swot Analysis: Visiopharm A/S
FIG 33 Swot Analysis: Indica Labs, Inc.

LAMEA Computational Pathology Market Size, Share & Trends Analysis Report By Component (Software and Services), By Application, By End-use, By Technology, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents